In situ hybridization detection kit for EZH2 gene, detection method and application thereof
A detection kit and in situ hybridization technology, applied in the field of kits, can solve problems such as heterogeneity, drug resistance of tumor cells, failure of anti-cancer battle, etc., and achieve the effect of convenient operation, high sensitivity and strong specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0044] An in situ hybridization detection kit for EZH2 gene, comprising a hybridization probe, a marker, and a synergist, wherein the sequence of the hybridization probe is shown in SEQ ID NO.1. Hybridization probes were labeled with digoxigenin. The composition of other liquids and specimens in the kit is as follows:
[0045] Digestive solution 100μl / tube 1 tube / box Colorless transparent liquid
[0046] Protective solution 100μl / tube 1 tube / box Colorless transparent liquid
[0047] Pre-hybridization solution 1300μl / tube 2 tubes / box Colorless transparent liquid
[0048] Sense hybridization solution 10μl / tube 1 tube / box Colorless transparent liquid
[0049] Antisense hybridization solution 10μl / tube 1 tube / box Colorless transparent liquid
[0050] Blocking solution 1000μl / tube 1 tube / box Colorless transparent liquid
[0051] Alkaline phosphatase antibody 1μl / tube 1 tube / box Colorless transparent liquid
[0052] Chromogen A 175μl / tube 1 tube / box Yellow liquid
[0053] Chr...
Embodiment 2
[0095] A kind of EZH2 gene in situ hybridization detection method and its kit application
[0096] 1. Specimen processing
[0097] 1. Use a 10ml centrifuge tube to fill 4.5ml of lymphocyte separation medium, then slowly add 3ml of anticoagulated blood into the centrifuge tube containing lymphocyte separation medium (blood: lymphocyte separation medium = 1:1.5), and centrifuge at 2000r / min 10min;
[0098] 2. Take the white blood cells in the middle layer into another centrifuge tube, then add about twice the amount of 1× buffer I to this tube, mix well, and centrifuge at 1500g / min for 10min;
[0099] 3. Discard the supernatant. Add about twice the 1× buffer I to the precipitate, mix well, and centrifuge at 1500g / min for 10min;
[0100] 4. Discard the supernatant, and absorb the excess liquid from the mouth of the test tube with paper towels. Then the precipitate was made into a suspension, dropped on a glass slide, and allowed to dry naturally. (Hospitals with conditions ca...
Embodiment 3
[0136] Parallel experiment between detection of metastatic disease of prostate cancer with EZH2 gene kit and detection of metastatic disease of prostate cancer with CA125 gene kit.
[0137] In order to scientifically evaluate the specificity, sensitivity and accuracy of the above genes in prostate cancer metastasis. We used the method of parallel experiments to detect the mRNA of the above genes at the same time. The detection technology used nucleic acid in situ hybridization technology to detect the EZH2 gene and CA125 (CA125 (tumor marker), NM -024690) mRNA of the gene (nucleic acid in situ hybridization, immunohistochemical staining, microscopic counting, result reporting, etc. all adopt the same methods, steps and reagents as the in situ hybridization techniques of Example 1 and Example 2). It was found that the expression level of EZH2 gene in patients with metastatic disease of prostate cancer was higher than that of CA125 gene in patients with the same disease. The re...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com